Alzheimer's Disease and the Disablement Process: Directions for Future Research

被引:0
作者
Dassel, Kara [1 ]
机构
[1] Barrow Neurol Inst, Phoenix, AZ 85721 USA
关键词
Disability; Alzheimer's disease; model;
D O I
10.1080/02703180902856240
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
The purpose of this theoretical paper is fourfold. First, the evolution of disability models is reviewed. Second, critique of current models and the need for an age-specific model is discussed. Third, the clinical symptoms of Alzheimer's disease (AD) including the physical disabilities that accompany the disease are addressed. Fourth, future directions in disability research in regards to AD are proposed. Disability models that are specific to persons with progressive cognitive disorders will aid in increasing researchers and clinicians understanding of the multifaceted and complex relationship between cognitive and physical impairments that characterize the disease trajectory of AD.
引用
收藏
页码:360 / 380
页数:21
相关论文
共 53 条
[1]  
[Anonymous], 2018, INT CLASS FUNCT DIS
[2]   One-year treatment of Alzheimer's disease with acetylcholinesterase inhibitors: improvement on ADAS-cog and TMT A, no change or worsening on other tests [J].
Borkowska, A ;
Ziolkowska-Kochan, M ;
Rybakowski, JK .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2005, 20 (06) :409-414
[3]   Concomitant use of medications with anticholinergic properties and acetylcholinesterase inhibitors: Impact on cognitive and physical functioning in Alzheimer disease [J].
Bottiggi, Kara A. ;
Salazar, Juan C. ;
Yu, Lei ;
Caban-Holt, Allison M. ;
Ryan, Melody ;
Schmitt, Frederick A. .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 15 (04) :357-359
[4]  
CBO, 1999, PROJ LONG TERM CAR S
[5]  
*CDC, 2001, PREV DIS ASS HLTH CO
[6]  
Chan DC, 2003, J GERONTOL A-BIOL, V58, P548
[7]  
Cummings J.L., 2003, NEUROPSYCHIATRY ALZH
[8]   A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease [J].
Farlow, M ;
Anand, R ;
Messina, J ;
Hartman, R ;
Veach, J .
EUROPEAN NEUROLOGY, 2000, 44 (04) :236-241
[9]  
Freedman M., 1994, CLOCK DRAWING NEUROP
[10]   Galantamine maintains ability to perform activities of daily living in patients with Alzheimer's disease [J].
Galasko, D ;
Kershaw, PR ;
Schneider, L ;
Zhu, Y ;
Tariot, PN .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (07) :1070-1076